Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis
Cell Proliferation · 2026
DOI: 10.1111/cpr.70141 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cell Proliferation, 2026. Verfasst von Wenkai Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Third School of Clinical Medicine, Beijing University of Traditional Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Mitochondria, Fatty Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mitochondrial quality control (MQC) impairment plays a central role in driving the pathogenesis of metabolism-associated steatotic liver disease (MASLD). Specifically, this is manifested as reduced mitophagy; increased mitochondrial fission and decreased fusion; and impaired mitochondrial biogenesis. Key pathological mechanisms of MASLD, such as hepatocyte apoptosis, pyroptosis, and ferroptosis, are activated under the influence of factors including free fatty acids (FFAs), oxidative stress, NLRP3 inflammasome activation, and gut microbiota imbalance. Meanwhile, the letter also lists novel potential therapeutic strategies targeting these pathways, including autophagy enhancers, mitochondrial dynamics regulators, biogenesis promoters, and ferroptosis inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Third School of Clinical Medicine, Beijing University of Traditional Chinese Medicine, Beijing, China.
- Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Cardiology, Senior Department of Cardiology, PLA General Hospital, Beijing, China.
- Cardiology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Gastroenterology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
ORCID-Profile: Wenkai Fu, Junqi Wang, Zhijiang Guo, Sang-Bing Ong, Hao Zhou, Xing Chang, Miao Meng
Zitieren
APA
Fu, W., Wang, J., Lu, N., Guo, Z., Ong, S. B., Gao, Y., Zhou, H., Chang, X., & Meng, M. (2026). Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis. Cell Proliferation. https://doi.org/10.1111/cpr.70141
Vancouver
Fu W, Wang J, Lu N, Guo Z, Ong SB, Gao Y, et al. Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis. Cell Proliferation. 2026. doi:10.1111/cpr.70141
BibTeX
@article{Fu2026,
author = {Fu, Wenkai and Wang, Junqi and Lu, Nan and Guo, Zhijiang and Ong, Sang-Bing and Gao, Yong and Zhou, Hao and Chang, Xing and Meng, Miao},
title = {Unveiling the Crucial Nexus: Mitochondrial Quality Control as a Central Driver in Metabolic Dysfunction‐Associated Steatotic Liver Disease Pathogenesis},
journal = {Cell Proliferation},
year = {2026},
doi = {10.1111/cpr.70141}
}
EUVIMED